ACR Convergence 2023

November 10-15, 2023. San Diego, CA.

View by Number View by Title View Sessions

Sunday, November 12, 2023

9:00AM-11:00AM: (0001–0008) B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: (0009–0012) Cytokines & Cell Trafficking Poster

9:00AM-11:00AM: (0013–0039.5) Genetics, Genomics & Proteomics Poster

9:00AM-11:00AM: (0040–0064) Innate Immunity Poster

9:00AM-11:00AM: (0066–0095) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: (0096–0116) Antiphospholipid Syndrome Poster

9:00AM-11:00AM: (0117–0144) Epidemiology & Public Health Poster I

9:00AM-11:00AM: (0145–0154) Epidemiology & Public Health – Interprofessional Poster

9:00AM-11:00AM: (0155–0175) Health Services Research Poster I

9:00AM-11:00AM: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

9:00AM-11:00AM: (0196–0228) Infection-related Rheumatic Disease Poster

9:00AM-11:00AM: (0229–0251) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

9:00AM-11:00AM: (0252–0282) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

9:00AM-11:00AM: (0283–0307) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I

9:00AM-11:00AM: (0308–0324) Osteoarthritis – Clinical Poster I

9:00AM-11:00AM: (0325–0344) Patient Outcomes, Preferences, & Attitudes Poster I

9:00AM-11:00AM: (0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA

9:00AM-11:00AM: (0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster I

9:00AM-11:00AM: (0423–0459) RA – Treatments Poster I

9:00AM-11:00AM: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

9:00AM-11:00AM: (0480–0482) Research Methodology – Interprofessional Poster

9:00AM-11:00AM: (0483–0509) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: PsA

9:00AM-11:00AM: (0510–0542) Spondyloarthritis Including Psoriatic Arthritis – Treatment: AxSpA Poster I

9:00AM-11:00AM: (0543–0581) SLE – Diagnosis, Manifestations, & Outcomes Poster I

9:00AM-11:00AM: (0582–0608) SLE – Treatment Poster I

9:00AM-11:00AM: (0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research

9:00AM-11:00AM: (0673–0690) Vasculitis – ANCA-Associated Poster I: Treatment Outcomes

9:00AM-11:00AM: (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

9:00AM-11:00AM: Patient Perspectives Poster

11:00AM-12:30PM: Plenary I

2:00PM-3:30PM: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease

2:00PM-3:30PM: Abstracts: Epidemiology & Public Health I

2:00PM-3:30PM: Abstracts: Genetics, Genomics & Proteomics

2:00PM-3:30PM: Abstracts: Imaging of Rheumatic Diseases

2:00PM-3:30PM: Abstracts: Measures & Measurement of Healthcare Quality

2:00PM-3:30PM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases I

2:00PM-3:30PM: Abstracts: Professional Education

2:00PM-3:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: RA-ILD

2:00PM-3:30PM: Abstracts: SLE – Treatment I: Renal

2:00PM-3:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment I: PsA

2:00PM-3:30PM: Abstracts: Systemic Sclerosis & Related Disorders I: Translational

4:00PM-5:30PM: Abstracts: Health Services Research I

4:00PM-5:30PM: Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science

4:00PM-5:30PM: Abstracts: Osteoarthritis I: Clinical Trials

4:00PM-5:30PM: Abstracts: Patient Outcomes, Preferences, & Attitudes I: Assessment Tools

4:00PM-5:30PM: Abstracts: Pediatric Rheumatology – Clinical I: JIA

4:00PM-5:30PM: Abstracts: RA – Animal Models

4:00PM-5:30PM: Abstracts: RA – Treatments I: Novel RA Treatments & Mechanisms of Action

4:00PM-5:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Biomarkers

4:00PM-5:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: AxSpA

4:00PM-5:30PM: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease

4:00PM-5:30PM: Abstracts: Vasculitis – ANCA-Associated I

4:00PM-5:00PM: Patient Perspectives

Monday, November 13, 2023

9:00AM-11:00AM: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

9:00AM-11:00AM: (0886–0898) SLE – Animal Models Poster

9:00AM-11:00AM: (0899–0933) SLE – Etiology & Pathogenesis Poster

9:00AM-11:00AM: (0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster

9:00AM-11:00AM: (0965–0992) Epidemiology & Public Health Poster II

9:00AM-11:00AM: (0993–1012) Health Services Research Poster II

9:00AM-11:00AM: (1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants

9:00AM-11:00AM: (1033–1051) Imaging of Rheumatic Diseases Poster I

9:00AM-11:00AM: (1052–1081) Immunological Complications of Medical Therapy Poster

9:00AM-11:00AM: (1082–1099) Measures & Measurement of Healthcare Quality Poster I

9:00AM-11:00AM: (1100–1123) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II

9:00AM-11:00AM: (1124–1154) Miscellaneous Rheumatic & Inflammatory Diseases Poster II

9:00AM-11:00AM: (1155–1182) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

9:00AM-11:00AM: (1183–1199) Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: (1200–1220) Patient Outcomes, Preferences, & Attitudes Poster II

9:00AM-11:00AM: (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

9:00AM-11:00AM: (1256–1263) Psychology/Social Science – Interprofessional Poster

9:00AM-11:00AM: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

9:00AM-11:00AM: (1308–1344) RA – Treatments Poster II

9:00AM-11:00AM: (1345–1364) Reproductive Issues in Rheumatic Disorders Poster II

9:00AM-11:00AM: (1365–1382) Sjögren’s Syndrome – Basic & Clinical Science Poster I

9:00AM-11:00AM: (1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS

9:00AM-11:00AM: (1412–1441) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II: SpA

9:00AM-11:00AM: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II

9:00AM-11:00AM: (1488–1512) SLE – Treatment Poster II

9:00AM-11:00AM: (1513–1533) Systemic Sclerosis & Related Disorders – Clinical Poster II: Clinical Trial, Treatment & Intervention

9:00AM-11:00AM: (1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification

9:00AM-11:00AM: (1554–1578) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

11:00AM-12:30PM: Plenary II

2:00PM-3:30PM: Abstracts: Antiphospholipid Syndrome

2:00PM-3:30PM: Abstracts: Fibromyalgia & Other Clinical Pain Syndromes

2:00PM-3:30PM: Abstracts: Health Services Research II

2:00PM-3:30PM: Abstracts: Innate Immunity

2:00PM-3:30PM: Abstracts: Interprofessional Exemplary

2:00PM-3:30PM: Abstracts: Osteoarthritis & Joint Biology – Basic Science

2:00PM-3:30PM: Abstracts: Pediatric Rheumatology – Clinical II: Connective Tissue Disease

2:00PM-3:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Comorbidities

2:00PM-3:30PM: Abstracts: Sjögren’s Syndrome – Basic & Clinical Science

2:00PM-3:30PM: Abstracts: SLE – Etiology & Pathogenesis

2:00PM-3:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes II: Psoriatic Arthritis

2:00PM-3:30PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Imaging

4:00PM-5:30PM: Abstracts: Infection-related Rheumatic Disease

4:00PM-5:30PM: Abstracts: Pediatric Rheumatology – Basic Science

4:00PM-5:30PM: Abstracts: RA – Treatments II: RA Treatment Safety

4:00PM-5:30PM: Abstracts: Reproductive Issues in Rheumatic Disorders

4:00PM-5:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Omics

4:00PM-5:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment II: PsA

4:00PM-5:30PM: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science

4:00PM-5:30PM: Abstracts: Systemic Sclerosis & Related Disorders II: Clinical Research

Tuesday, November 14, 2023

9:00AM-11:00AM: (1705–1712) Pediatric Rheumatology – Basic Science Poster

9:00AM-11:00AM: (1713–1733) RA – Animal Models Poster

9:00AM-11:00AM: (1734–1775) RA – Etiology and Pathogenesis Poster

9:00AM-11:00AM: (1776–1795) Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

9:00AM-11:00AM: (1796–1826) Epidemiology & Public Health Poster III

9:00AM-11:00AM: (1827–1839) Fibromyalgia & Other Clinical Pain Syndromes Poster

9:00AM-11:00AM: (1840–1861) Health Services Research Poster III

9:00AM-11:00AM: (1862–1894) Imaging of Rheumatic Diseases Poster II

9:00AM-11:00AM: (1895–1912) Measures & Measurement of Healthcare Quality Poster II

9:00AM-11:00AM: (1913–1944) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

9:00AM-11:00AM: (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

9:00AM-11:00AM: (1973–1976) Orthopedics, Low Back Pain, & Rehabilitation Poster

9:00AM-11:00AM: (1977–1995) Osteoarthritis – Clinical Poster III

9:00AM-11:00AM: (1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

9:00AM-11:00AM: (2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III

9:00AM-11:00AM: (2039–2060) Pediatric Rheumatology – Clinical Poster III: Potpourri

9:00AM-11:00AM: (2061–2088) Professional Education Poster

9:00AM-11:00AM: (2089–2094) Patient Education/Community Service – Interprofessional Poster

9:00AM-11:00AM: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

9:00AM-11:00AM: (2141–2176) RA – Treatments Poster III

9:00AM-11:00AM: (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II

9:00AM-11:00AM: (2195–2226) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: SpA

9:00AM-11:00AM: (2227–2256) Spondyloarthritis Including Psoriatic Arthritis – Treatment: SpA Poster III

9:00AM-11:00AM: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

9:00AM-11:00AM: (2326–2351) SLE – Treatment Poster III

9:00AM-11:00AM: (2352–2369) Systemic Sclerosis & Related Disorders – Clinical Poster III: Translational Science

9:00AM-11:00AM: (2370–2386) Vasculitis – ANCA-Associated Poster III: Biomarkers & Renal Outcomes

9:00AM-11:00AM: (2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

9:00AM-11:00AM: Late-Breaking Abstract Poster

11:00AM-12:30PM: Plenary III

2:00PM-3:30PM: Abstracts: Epidemiology & Public Health II

2:00PM-3:30PM: Abstracts: Healthcare Disparities in Rheumatology

2:00PM-3:30PM: Abstracts: Interprofessional OA & Lupus

2:00PM-3:30PM: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I

2:00PM-3:30PM: Abstracts: Osteoarthritis II: Novel Insights from Observational Studies

2:00PM-3:30PM: Abstracts: Pediatric Rheumatology – Clinical III: Potpourri

2:00PM-3:30PM: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Predicting & Optimizing Outcomes

2:00PM-3:30PM: Abstracts: RA – Etiology & Pathogenesis

2:00PM-3:30PM: Abstracts: SLE – Animal Models

2:00PM-3:30PM: Abstracts: SLE – Treatment II: Nonrenal

2:00PM-3:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Basic Science

2:00PM-3:30PM: Abstracts: Vasculitis – ANCA-Associated II

4:00PM-5:30PM: Abstracts: Cytokines & Cell Trafficking

4:00PM-5:30PM: Abstracts: Immunological Complications of Medical Therapy

4:00PM-5:30PM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II

4:00PM-5:30PM: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

4:00PM-5:30PM: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science

4:00PM-5:30PM: Abstracts: Patient Outcomes, Preferences, & Attitudes II: Patient Experience

4:00PM-5:30PM: Abstracts: RA – Treatments III: Predictors of Response & Tapering

4:00PM-5:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Disease Activity

4:00PM-5:30PM: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment III: AxSpA

4:00PM-5:30PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II: Clinical

Wednesday, November 15, 2023

7:30AM-9:00AM: Late-Breaking Abstract Session

9:00AM-10:30AM: Abstracts: Epidemiology & Public Health III

9:00AM-10:30AM: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases III

9:00AM-10:30AM: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II

11:00AM-12:30PM: Abstracts: RA – Diagnosis, Manifestations, and Outcomes IV: Pre-RA & RA Diagnosis

11:00AM-12:30PM: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes IV: Outcomes & Comorbidity

11:00AM-12:30PM: Abstracts: Systemic Sclerosis & Related Disorders III: Clinical Trials

11:00AM-12:30PM: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders III: Innovation

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].